Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
entecavir (baraclude) (2 trials)
fuzhenghuayu (2 trials)
Fibrosis (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Liver Cirrhosis (Phase 4)
Trials (2 total)
Trial APIs (2 total)